Protocol for germ lineage differentiation of primed human pluripotent stem cells using chemically defined, nutrient-balanced media
Year: 2022
Type: article
Abstract: Metabolism regulates cell fates during early mammalian cell differentiation. This protocol describes the steps for directed differentiation of primed human pluripotent stem cells (hPSCs) into the three primary germ lineages—ectoderm, endoderm, and mesoderm—using a chemically defined nutrient-balanced media formulation. Although the transient removal and addition of specific nutrients does not occur in vivo during embryonic development, manipulation of nutrients in vitro provides an accessible method for evaluating how extracellular and intracellular metabolites help determine hPSC fate. For complete details on the use and execution of this protocol, please refer to Lu et al. (2019) 12. Lu, V. ∙ Dahan, P. ∙ Ahsan, F.M. ... Mitochondrial metabolism and glutamine are essential for mesoderm differentiation of human pluripotent stem cells Cell Res. 2019; 29 :596-598 Google Scholar and Lu et al. (2022) 14. Lu, V. ∙ Roy, I.J. ∙ Torres, Jr., A. ... Glutamine-dependent signaling controls pluripotent stem cell fate Dev. Cell. 2022; 57 :610-623.e8 Google Scholar .
Source: STAR Protocols
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $1,500
Funders: National Science Foundation, U.S. Department of Defense, Israel National Road Safety Authority, National Institutes of Health, National Cancer Institute, National Institute of General Medical Sciences, Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University of California Los Angeles, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Air Force Office of Scientific Research
Awards: G1820511087, G1941060891, G2341660198, G2768817213, G3497857942, SPOTs: Optical Technologies for Instantly Quantifying Multicellular Response Profiles, ENGINEERING CARDIOMYOCYTE FUNCTION BY CONTROLLED MITOCHONDRIAL TRANSFER, G4805816520, G5612156866, G5775360194, G6318647045, G6487559069, (PQ5) Mitochondrial Transfer in Tumor Heterogeneity and Acquired Resistence to Therapy, G8923277708, G9000095890, G9000135771, Cancer Center Support Grant
OpenAlex ID: W4285891028
